Table 2.

Predictors of worsened neuropsychiatric symptoms.

Variable	Depression		Apathy		Delusions		Anxiety		Irritability
	p	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)
Survey completion (Days since 100 cases)	0.386	0.99 (0.98–1.01)	0.075	1.01 (0.99–1.03)	0.006	1.02 (1.01–1.04)	0.254	1.01 (0.99–1.02)	0.612	1.00 (0.99–1.02)
Age (Patient)	0.269	1.03 (0.98–1.08)	0.397	1.02 (0.97–1.03)	0.185	1.04 (0.98–1.10)	0.484	1.02 (0.97–1.07)	0.028	1.08 (1.01–1.15)
Sex (Patient)
Male	–	–	–	–	–	–	–	–	–	–
Female	0.436	1.39 (0.61–3.18)	0.294	0.60 (0.23–1.56)	0.111	0.47 (0.18–1.19)	0.984	0.96 (0.38–2.44)	0.067	0.40 (0.15–1.07)
Country
Australia	0.745	0.80 (0.20–3.15)	0.076	5.64 (0.83–38.10)	0.340	2.01 (0.48–8.37)	0.417	0.56 (0.13–2.30)	0.336	2.06 (0.47–8.96)
Germany	0.141	0.42 (0.13–1.33)	–		0.000	0.05 (0.01–0.22)	0.100	0.36 (0.11–1.22)	0.068	0.25 (0.06–1.11)
Spain	–	–	0.006	6.18 (1.69–22.68)	–	–	–	–	–	–
Region
Urban	–	–	–	–	–	–	–	–	–	–
Regional	0.097	2.15 (0.87–5.29)	0.001	5.89 (2.04–16.97)	0.174	2.06 (0.73–5.84)	0.508	1.40 (0.52–3.78)	0.987	0.99 (0.34–2.93)
Diagnosis
AD	0.362	0.57 (0.17–1.92)	–	–	0.215	0.43 (0.11–1.63)	0.503	1.43 (0.50–4.06)	0.639	1.45 (0.31–6.77)
FTD	0.910	0.93 (0.27–3.27)	0.705	0.81 (0.27–2.42)	0.181	0.39 (0.10–1.56)	0.171	0.39 (0.10–1.51)	0.456	1.84 (0.37–9.07)
Other dementia	–	–	0.002	8.39 (2.14–32.88)	–	–	–	–	–	–
Living with
Yes	–	–	–	–	–	–	–	–	–	–
No	0.002	3.76 (1.61–8.82)	0.477	1.40 (0.56–3.51)	0.015	3.25 (1.25–8.46)	0.002	4.17 (1.70–10.24)	0.399	1.52 (0.58–4.02)
COVID-19 awareness
Yes	0.299	0.54 (0.16–1.74)	0.748	0.82 (0.25–2.69)	0.481	0.64 (0.18–2.24)	0.046	3.64 (1.02–12.95)	0.140	0.39 (0.11–1.36)
No	–	–	–	–	–	–	–	–	–	–
COVID-19 understanding
None/limited	0.046	3.01 (1.02–8.89)	0.001	7.90 (2.29–27.30)	0.003	6.00 (1.82–19.81)	0.004	5.99 (1.76–16.52)	0.008	5.04 (1.54–16.52)
Moderate/good	–	–	–	–	–	–	–	–	–	–

Significant values are in bold.

Responses of “unsure” were not included in the regression analyses.